Page last updated: 2024-09-03

2-(3,4-dichlorophenyl)-n-methyl-n-(1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl)acetamide and Muscle Contraction

2-(3,4-dichlorophenyl)-n-methyl-n-(1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl)acetamide has been researched along with Muscle Contraction in 1 studies

*Muscle Contraction: A process leading to shortening and/or development of tension in muscle tissue. Muscle contraction occurs by a sliding filament mechanism whereby actin filaments slide inward among the myosin filaments. [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, AC; Gleason, WB; Ojala, WH; Portoghese, PS; Takemori, AE1

Other Studies

1 other study(ies) available for 2-(3,4-dichlorophenyl)-n-methyl-n-(1-(3-isothiocyanatophenyl)-2-(1-pyrrolidinyl)ethyl)acetamide and Muscle Contraction

ArticleYear
kappa Opioid receptor selective affinity labels: electrophilic benzeneacetamides as kappa-selective opioid antagonists.
    Journal of medicinal chemistry, 1994, Dec-23, Volume: 37, Issue:26

    Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Acetamides; Affinity Labels; Analgesics; Animals; Crystallography, X-Ray; Guinea Pigs; In Vitro Techniques; Isothiocyanates; Male; Mice; Models, Molecular; Molecular Conformation; Muscle Contraction; Pyrrolidines; Receptors, Opioid, kappa; Structure-Activity Relationship

1994